Connection

Sacha Gnjatic to Immunotherapy

Back to Details
This is a "connection" page, showing publications Sacha Gnjatic has written about Immunotherapy.
Sacha Gnjatic
Connection Strength
0.787
Immunotherapy
  1. Cancer Immunotherapy: From local to global. Nat Nanotechnol. 2017 09 06; 12(9):840-841.
    View in: PubMed
    Score: 0.261
  2. Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy. J Immunother Cancer. 2017; 5:44.
    View in: PubMed
    Score: 0.255
  3. Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy. J Immunother Cancer. 2021 05; 9(5).
    View in: PubMed
    Score: 0.084
  4. Immunotherapy biomarkers 2016: overcoming the barriers. J Immunother Cancer. 2017 03 21; 5(1):29.
    View in: PubMed
    Score: 0.063
  5. MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy. Oncotarget. 2017 Feb 28; 8(9):14719-14735.
    View in: PubMed
    Score: 0.063
  6. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clin Cancer Res. 2012 Oct 01; 18(19):5449-59.
    View in: PubMed
    Score: 0.046
  7. NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer. Gynecol Oncol. 2017 06; 145(3):420-425.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.